Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gray

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Genes|August 29, 2024
Tracking Ovine Pulmonary Adenocarcinoma Development Using an Experimental Jaagsiekte Sheep Retrovirus Infection ModelChris Cousens, James Meehan, David Collie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2025
AAV-delivered PPT1 provides long-term neurological benefits in CLN1 mice and achieves therapeutic levels in sheep brainMd Suhail Alam, Apeksha Khatiwada, Samantha L Eaton, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Genes|August 29, 2024
Tracking Ovine Pulmonary Adenocarcinoma Development Using an Experimental Jaagsiekte Sheep Retrovirus Infection ModelChris Cousens, James Meehan, David Collie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2025
AAV-delivered PPT1 provides long-term neurological benefits in CLN1 mice and achieves therapeutic levels in sheep brainMd Suhail Alam, Apeksha Khatiwada, Samantha L Eaton, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
Pageof 7